{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T23:58:58Z","timestamp":1790380738104,"version":"4.1.0"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,3,27]],"date-time":"2018-03-27T00:00:00Z","timestamp":1522108800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2018,3,27]],"date-time":"2018-03-27T00:00:00Z","timestamp":1522108800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004330","name":"Smoking Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004330","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP16K08994"],"award-info":[{"award-number":["JP16K08994"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP15K10563"],"award-info":[{"award-number":["JP15K10563"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroinflammation"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12974-018-1133-5","type":"journal-article","created":{"date-parts":[[2018,4,4]],"date-time":"2018-04-04T00:06:58Z","timestamp":1522800418000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":54,"title":["Inhibition of peripheral macrophages by nicotinic acetylcholine receptor agonists suppresses spinal microglial activation and neuropathic pain in mice with peripheral nerve injury"],"prefix":"10.1186","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5401-8650","authenticated-orcid":false,"given":"Norikazu","family":"Kiguchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daichi","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumihiro","family":"Saika","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinsuke","family":"Matsuzaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiroh","family":"Kishioka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,3,27]]},"reference":[{"key":"1133_CR1","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/S1474-4422(10)70143-5","volume":"9","author":"R Baron","year":"2010","unstructured":"Baron R, Binder A, Wasner G. Neuropathic pain: diagnosis, pathophysiological mechanisms, and treatment. Lancet Neurol. 2010;9:807\u201319.","journal-title":"Lancet Neurol"},{"key":"1133_CR2","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1016\/S1474-4422(14)70102-4","volume":"13","author":"TS Jensen","year":"2014","unstructured":"Jensen TS, Finnerup NB. Allodynia and hyperalgesia in neuropathic pain: clinical manifestations and mechanisms. Lancet Neurol. 2014;13:924\u201335.","journal-title":"Lancet Neurol"},{"key":"1133_CR3","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/S1474-4422(14)70251-0","volume":"14","author":"NB Finnerup","year":"2015","unstructured":"Finnerup NB, Attal N, Haroutounian S, McNicol E, Baron R, Dworkin RH, Gilron I, Haanpaa M, Hansson P, Jensen TS, et al. Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis. Lancet Neurol. 2015;14:162\u201373.","journal-title":"Lancet Neurol"},{"key":"1133_CR4","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.neuron.2006.09.021","volume":"52","author":"JN Campbell","year":"2006","unstructured":"Campbell JN, Meyer RA. Mechanisms of neuropathic pain. Neuron. 2006;52:77\u201392.","journal-title":"Neuron"},{"key":"1133_CR5","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S1474-4422(12)70134-5","volume":"11","author":"M Calvo","year":"2012","unstructured":"Calvo M, Dawes JM, Bennett DL. The role of the immune system in the generation of neuropathic pain. Lancet Neurol. 2012;11:629\u201342.","journal-title":"Lancet Neurol"},{"key":"1133_CR6","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1038\/nn1992","volume":"10","author":"J Scholz","year":"2007","unstructured":"Scholz J, Woolf CJ. The neuropathic pain triad: neurons, immune cells and glia. Nat Neurosci. 2007;10:1361\u20138.","journal-title":"Nat Neurosci"},{"key":"1133_CR7","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1213\/01.ane.0000275190.42912.37","volume":"105","author":"MA Thacker","year":"2007","unstructured":"Thacker MA, Clark AK, Marchand F, McMahon SB. Pathophysiology of peripheral neuropathic pain: immune cells and molecules. Anesth Analg. 2007;105:838\u201347.","journal-title":"Anesth Analg"},{"key":"1133_CR8","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1038\/nm.2234","volume":"16","author":"K Ren","year":"2010","unstructured":"Ren K, Dubner R. Interactions between the immune and nervous systems in pain. Nat Med. 2010;16:1267\u201376.","journal-title":"Nat Med"},{"key":"1133_CR9","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.pain.2010.02.025","volume":"149","author":"N Kiguchi","year":"2010","unstructured":"Kiguchi N, Maeda T, Kobayashi Y, Fukazawa Y, Kishioka S. Macrophage inflammatory protein-1alpha mediates the development of neuropathic pain following peripheral nerve injury through interleukin-1beta up-regulation. Pain. 2010;149:305\u201315.","journal-title":"Pain"},{"key":"1133_CR10","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1002\/j.1532-2149.2012.00146.x","volume":"16","author":"F Saika","year":"2012","unstructured":"Saika F, Kiguchi N, Kobayashi Y, Fukazawa Y, Kishioka S. CC-chemokine ligand 4\/macrophage inflammatory protein-1beta participates in the induction of neuropathic pain after peripheral nerve injury. Eur J Pain. 2012;16:1271\u201380.","journal-title":"Eur J Pain"},{"key":"1133_CR11","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.coph.2011.10.007","volume":"12","author":"N Kiguchi","year":"2012","unstructured":"Kiguchi N, Kobayashi Y, Kishioka S. Chemokines and cytokines in neuroinflammation leading to neuropathic pain. Curr Opin Pharmacol. 2012;12:55\u201361.","journal-title":"Curr Opin Pharmacol"},{"issue":"Pt A","key":"1133_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neulet.2013.10.004","volume":"557","author":"JM Dawes","year":"2013","unstructured":"Dawes JM, McMahon SB. Chemokines as peripheral pain mediators. Neurosci Lett. 2013;557(Pt A):1\u20138.","journal-title":"Neurosci Lett"},{"key":"1133_CR13","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1126\/science.aaf8924","volume":"354","author":"RR Ji","year":"2016","unstructured":"Ji RR, Chamessian A, Zhang YQ. Pain regulation by non-neuronal cells and inflammation. Science. 2016;354:572\u20137.","journal-title":"Science"},{"key":"1133_CR14","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/S0306-4522(02)00065-9","volume":"112","author":"P Hu","year":"2002","unstructured":"Hu P, McLachlan EM. Macrophage and lymphocyte invasion of dorsal root ganglia after peripheral nerve lesions in the rat. Neuroscience. 2002;112:23\u201338.","journal-title":"Neuroscience"},{"key":"1133_CR15","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.jneuroim.2006.12.009","volume":"184","author":"N Morin","year":"2007","unstructured":"Morin N, Owolabi SA, Harty MW, Papa EF, Tracy TF Jr, Shaw SK, Kim M, Saab CY. Neutrophils invade lumbar dorsal root ganglia after chronic constriction injury of the sciatic nerve. J Neuroimmunol. 2007;184:164\u201371.","journal-title":"J Neuroimmunol"},{"key":"1133_CR16","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.it.2004.09.015","volume":"25","author":"A Mantovani","year":"2004","unstructured":"Mantovani A, Sica A, Sozzani S, Allavena P, Vecchi A, Locati M. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol. 2004;25:677\u201386.","journal-title":"Trends Immunol"},{"key":"1133_CR17","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1038\/ni.1937","volume":"11","author":"SK Biswas","year":"2010","unstructured":"Biswas SK, Mantovani A. Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm. Nat Immunol. 2010;11:889\u201396.","journal-title":"Nat Immunol"},{"key":"1133_CR18","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.cell.2010.02.029","volume":"140","author":"C Nathan","year":"2010","unstructured":"Nathan C, Ding A. Nonresolving inflammation. Cell. 2010;140:871\u201382.","journal-title":"Cell"},{"key":"1133_CR19","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1016\/j.lfs.2013.10.005","volume":"93","author":"V Ristoiu","year":"2013","unstructured":"Ristoiu V. Contribution of macrophages to peripheral neuropathic pain pathogenesis. Life Sci. 2013;93:870\u201381.","journal-title":"Life Sci"},{"key":"1133_CR20","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1097\/j.pain.0000000000000097","volume":"156","author":"N Kiguchi","year":"2015","unstructured":"Kiguchi N, Kobayashi Y, Saika F, Sakaguchi H, Maeda T, Kishioka S. Peripheral interleukin-4 ameliorates inflammatory macrophage-dependent neuropathic pain. Pain. 2015;156:684\u201393.","journal-title":"Pain"},{"key":"1133_CR21","doi-asserted-by":"publisher","first-page":"12603","DOI":"10.1074\/jbc.M115.636506","volume":"290","author":"Y Kobayashi","year":"2015","unstructured":"Kobayashi Y, Kiguchi N, Fukazawa Y, Saika F, Maeda T, Kishioka S. Macrophage-T cell interactions mediate neuropathic pain through the glucocorticoid-induced tumor necrosis factor ligand system. J Biol Chem. 2015;290:12603\u201313.","journal-title":"J Biol Chem"},{"key":"1133_CR22","doi-asserted-by":"crossref","unstructured":"Kiguchi N, Kobayashi D, Saika F, Matsuzaki S, Kishioka S. Pharmacological regulation of neuropathic pain driven by inflammatory macrophages. Int J Mol Sci. 2017;18:E2296.","DOI":"10.3390\/ijms18112296"},{"key":"1133_CR23","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/BF02740634","volume":"15","author":"J Lindstrom","year":"1997","unstructured":"Lindstrom J. Nicotinic acetylcholine receptors in health and disease. Mol Neurobiol. 1997;15:193\u2013222.","journal-title":"Mol Neurobiol"},{"key":"1133_CR24","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.neuron.2011.03.014","volume":"70","author":"JM Miwa","year":"2011","unstructured":"Miwa JM, Freedman R, Lester HA. Neural systems governed by nicotinic acetylcholine receptors: emerging hypotheses. Neuron. 2011;70:20\u201333.","journal-title":"Neuron"},{"key":"1133_CR25","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1038\/nm1124","volume":"10","author":"H Wang","year":"2004","unstructured":"Wang H, Liao H, Ochani M, Justiniani M, Lin X, Yang L, Al-Abed Y, Wang H, Metz C, Miller EJ, et al. Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis. Nat Med. 2004;10:1216\u201321.","journal-title":"Nat Med"},{"key":"1133_CR26","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1038\/ni1229","volume":"6","author":"WJ de Jonge","year":"2005","unstructured":"de Jonge WJ, van der Zanden EP, The FO, Bijlsma MF, van Westerloo DJ, Bennink RJ, Berthoud HR, Uematsu S, Akira S, van den Wijngaard RM, Boeckxstaens GE. Stimulation of the vagus nerve attenuates macrophage activation by activating the Jak2-STAT3 signaling pathway. Nat Immunol. 2005;6:844\u201351.","journal-title":"Nat Immunol"},{"key":"1133_CR27","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/nrd1797","volume":"4","author":"L Ulloa","year":"2005","unstructured":"Ulloa L. The vagus nerve and the nicotinic anti-inflammatory pathway. Nat Rev Drug Discov. 2005;4:673\u201384.","journal-title":"Nat Rev Drug Discov"},{"key":"1133_CR28","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1016\/j.neuint.2012.09.001","volume":"61","author":"N Kiguchi","year":"2012","unstructured":"Kiguchi N, Kobayashi Y, Maeda T, Tominaga S, Nakamura J, Fukazawa Y, Ozaki M, Kishioka S. Activation of nicotinic acetylcholine receptors on bone marrow-derived cells relieves neuropathic pain accompanied by peripheral neuroinflammation. Neurochem Int. 2012;61:1212\u20139.","journal-title":"Neurochem Int"},{"key":"1133_CR29","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1111\/apha.12437","volume":"213","author":"F Saika","year":"2015","unstructured":"Saika F, Kiguchi N, Kobayashi Y, Kishioka S. Peripheral alpha4beta2 nicotinic acetylcholine receptor signalling attenuates tactile allodynia and thermal hyperalgesia after nerve injury in mice. Acta Physiol (Oxf). 2015;213:462\u201371.","journal-title":"Acta Physiol (Oxf)"},{"key":"1133_CR30","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/1744-8069-3-27","volume":"3","author":"AF Keller","year":"2007","unstructured":"Keller AF, Beggs S, Salter MW, De Koninck Y. Transformation of the output of spinal lamina I neurons after nerve injury and microglia stimulation underlying neuropathic pain. Mol Pain. 2007;3:27.","journal-title":"Mol Pain"},{"key":"1133_CR31","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1016\/j.neuron.2012.02.008","volume":"73","author":"CA von Hehn","year":"2012","unstructured":"von Hehn CA, Baron R, Woolf CJ. Deconstructing the neuropathic pain phenotype to reveal neural mechanisms. Neuron. 2012;73:638\u201352.","journal-title":"Neuron"},{"key":"1133_CR32","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1016\/j.pain.2014.03.022","volume":"155","author":"S Haroutounian","year":"2014","unstructured":"Haroutounian S, Nikolajsen L, Bendtsen TF, Finnerup NB, Kristensen AD, Hasselstrom JB, Jensen TS. Primary afferent input critical for maintaining spontaneous pain in peripheral neuropathy. Pain. 2014;155:1272\u20139.","journal-title":"Pain"},{"key":"1133_CR33","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/nri3621","volume":"14","author":"PM Grace","year":"2014","unstructured":"Grace PM, Hutchinson MR, Maier SF, Watkins LR. Pathological pain and the neuroimmune interface. Nat Rev Immunol. 2014;14:217\u201331.","journal-title":"Nat Rev Immunol"},{"key":"1133_CR34","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1038\/nrd4334","volume":"13","author":"RR Ji","year":"2014","unstructured":"Ji RR, Xu ZZ, Gao YJ. Emerging targets in neuroinflammation-driven chronic pain. Nat Rev Drug Discov. 2014;13:533\u201348.","journal-title":"Nat Rev Drug Discov"},{"key":"1133_CR35","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.neuropharm.2015.08.042","volume":"104","author":"M Tsuda","year":"2016","unstructured":"Tsuda M, Inoue K. Neuron-microglia interaction by purinergic signaling in neuropathic pain following neurodegeneration. Neuropharmacology. 2016;104:76\u201381.","journal-title":"Neuropharmacology"},{"key":"1133_CR36","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/0304-3959(90)91074-S","volume":"43","author":"Z Seltzer","year":"1990","unstructured":"Seltzer Z, Dubner R, Shir Y. A novel behavioral model of neuropathic pain disorders produced in rats by partial sciatic nerve injury. Pain. 1990;43:205\u201318.","journal-title":"Pain"},{"key":"1133_CR37","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1124\/jpet.111.187724","volume":"340","author":"N Kiguchi","year":"2012","unstructured":"Kiguchi N, Kobayashi Y, Maeda T, Fukazawa Y, Tohya K, Kimura M, Kishioka S. Epigenetic augmentation of the macrophage inflammatory protein 2\/C-X-C chemokine receptor type 2 axis through histone H3 acetylation in injured peripheral nerves elicits neuropathic pain. J Pharmacol Exp Ther. 2012;340:577\u201387.","journal-title":"J Pharmacol Exp Ther"},{"key":"1133_CR38","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/0165-0270(94)90144-9","volume":"53","author":"SR Chaplan","year":"1994","unstructured":"Chaplan SR, Bach FW, Pogrel JW, Chung JM, Yaksh TL. Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods. 1994;53:55\u201363.","journal-title":"J Neurosci Methods"},{"key":"1133_CR39","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S0140-6736(06)69005-3","volume":"368","author":"KA Brown","year":"2006","unstructured":"Brown KA, Brain SD, Pearson JD, Edgeworth JD, Lewis SM, Treacher DF. Neutrophils in development of multiple organ failure in sepsis. Lancet. 2006;368:157\u201369.","journal-title":"Lancet"},{"key":"1133_CR40","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1158\/2326-6066.CIR-13-0117","volume":"1","author":"Y Lavin","year":"2013","unstructured":"Lavin Y, Merad M. Macrophages: gatekeepers of tissue integrity. Cancer Immunol Res. 2013;1:201\u20139.","journal-title":"Cancer Immunol Res"},{"key":"1133_CR41","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1084\/jem.20160470","volume":"214","author":"LM Connor","year":"2017","unstructured":"Connor LM, Tang SC, Cognard E, Ochiai S, Hilligan KL, Old SI, Pellefigues C, White RF, Patel D, Smith AA, et al. Th2 responses are primed by skin dendritic cells with distinct transcriptional profiles. J Exp Med. 2017;214:125\u201342.","journal-title":"J Exp Med"},{"key":"1133_CR42","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.jphs.2016.11.005","volume":"133","author":"N Kiguchi","year":"2017","unstructured":"Kiguchi N, Sakaguchi H, Kadowaki Y, Saika F, Fukazawa Y, Matsuzaki S, Kishioka S. Peripheral administration of interleukin-13 reverses inflammatory macrophage and tactile allodynia in mice with partial sciatic nerve ligation. J Pharmacol Sci. 2017;133:53\u20136.","journal-title":"J Pharmacol Sci"},{"key":"1133_CR43","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1038\/nature01339","volume":"421","author":"H Wang","year":"2003","unstructured":"Wang H, Yu M, Ochani M, Amella CA, Tanovic M, Susarla S, Li JH, Wang H, Yang H, Ulloa L, et al. Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation. Nature. 2003;421:384\u20138.","journal-title":"Nature"},{"key":"1133_CR44","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1172\/JCI30555","volume":"117","author":"KJ Tracey","year":"2007","unstructured":"Tracey KJ. Physiology and immunology of the cholinergic antiinflammatory pathway. J Clin Invest. 2007;117:289\u201396.","journal-title":"J Clin Invest"},{"key":"1133_CR45","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1111\/j.1471-4159.2009.06373.x","volume":"111","author":"V Hosur","year":"2009","unstructured":"Hosur V, Leppanen S, Abutaha A, Loring RH. Gene regulation of alpha4beta2 nicotinic receptors: microarray analysis of nicotine-induced receptor up-regulation and anti-inflammatory effects. J Neurochem. 2009;111:848\u201358.","journal-title":"J Neurochem"},{"key":"1133_CR46","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1053\/j.gastro.2009.04.057","volume":"137","author":"EP van der Zanden","year":"2009","unstructured":"van der Zanden EP, Snoek SA, Heinsbroek SE, Stanisor OI, Verseijden C, Boeckxstaens GE, Peppelenbosch MP, Greaves DR, Gordon S, De Jonge WJ. Vagus nerve activity augments intestinal macrophage phagocytosis via nicotinic acetylcholine receptor alpha4beta2. Gastroenterology. 2009;137:1029\u201339. 39 e1-4","journal-title":"Gastroenterology"},{"key":"1133_CR47","doi-asserted-by":"publisher","first-page":"e79264","DOI":"10.1371\/journal.pone.0079264","volume":"8","author":"A Nemethova","year":"2013","unstructured":"Nemethova A, Michel K, Gomez-Pinilla PJ, Boeckxstaens GE, Schemann M. Nicotine attenuates activation of tissue resident macrophages in the mouse stomach through the beta2 nicotinic acetylcholine receptor. PLoS One. 2013;8:e79264.","journal-title":"PLoS One"},{"key":"1133_CR48","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.bbrc.2009.04.121","volume":"384","author":"N Kiguchi","year":"2009","unstructured":"Kiguchi N, Maeda T, Kobayashi Y, Fukazawa Y, Kishioka S. Leptin enhances CC-chemokine ligand expression in cultured murine macrophage. Biochem Biophys Res Commun. 2009;384:311\u20135.","journal-title":"Biochem Biophys Res Commun"},{"key":"1133_CR49","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.jphs.2015.04.009","volume":"128","author":"N Kiguchi","year":"2015","unstructured":"Kiguchi N, Saika F, Kobayashi Y, Ko MC, Kishioka S. TC-2559, an alpha4beta2 nicotinic acetylcholine receptor agonist, suppresses the expression of CCL3 and IL-1beta through STAT3 inhibition in cultured murine macrophages. J Pharmacol Sci. 2015;128:83\u20136.","journal-title":"J Pharmacol Sci"},{"key":"1133_CR50","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.ejphar.2013.04.021","volume":"712","author":"R Nirogi","year":"2013","unstructured":"Nirogi R, Goura V, Abraham R, Jayarajan P. alpha4beta2* neuronal nicotinic receptor ligands (agonist, partial agonist and positive allosteric modulators) as therapeutic prospects for pain. Eur J Pharmacol. 2013;712:22\u20139.","journal-title":"Eur J Pharmacol"},{"key":"1133_CR51","doi-asserted-by":"crossref","first-page":"5426","DOI":"10.1523\/JNEUROSCI.18-14-05426.1998","volume":"18","author":"RS Bitner","year":"1998","unstructured":"Bitner RS, Nikkel AL, Curzon P, Arneric SP, Bannon AW, Decker MW. Role of the nucleus raphe magnus in antinociception produced by ABT-594: immediate early gene responses possibly linked to neuronal nicotinic acetylcholine receptors on serotonergic neurons. J Neurosci. 1998;18:5426\u201332.","journal-title":"J Neurosci"},{"key":"1133_CR52","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1124\/jpet.104.079368","volume":"313","author":"G Cucchiaro","year":"2005","unstructured":"Cucchiaro G, Chaijale N, Commons KG. The dorsal raphe nucleus as a site of action of the antinociceptive and behavioral effects of the alpha4 nicotinic receptor agonist epibatidine. J Pharmacol Exp Ther. 2005;313:389\u201394.","journal-title":"J Pharmacol Exp Ther"},{"key":"1133_CR53","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/S0006-8993(02)03270-5","volume":"953","author":"MH Rashid","year":"2002","unstructured":"Rashid MH, Ueda H. Neuropathy-specific analgesic action of intrathecal nicotinic agonists and its spinal GABA-mediated mechanism. Brain Res. 2002;953:53\u201362.","journal-title":"Brain Res"},{"key":"1133_CR54","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/1744-8069-7-56","volume":"7","author":"LZ Cheng","year":"2011","unstructured":"Cheng LZ, Han L, Fan J, Huang LT, Peng LC, Wang Y. Enhanced inhibitory synaptic transmission in the spinal dorsal horn mediates antinociceptive effects of TC-2559. Mol Pain. 2011;7:56.","journal-title":"Mol Pain"},{"key":"1133_CR55","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/S0014-2999(00)00807-4","volume":"409","author":"M Bencherif","year":"2000","unstructured":"Bencherif M, Bane AJ, Miller CH, Dull GM, Gatto GJ. TC-2559: a novel orally active ligand selective at neuronal acetylcholine receptors. Eur J Pharmacol. 2000;409:45\u201355.","journal-title":"Eur J Pharmacol"},{"key":"1133_CR56","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/S0028-3908(03)00189-8","volume":"45","author":"Y Chen","year":"2003","unstructured":"Chen Y, Sharples TJ, Phillips KG, Benedetti G, Broad LM, Zwart R, Sher E. The nicotinic alpha 4 beta 2 receptor selective agonist, TC-2559, increases dopamine neuronal activity in the ventral tegmental area of rat midbrain slices. Neuropharmacology. 2003;45:334\u201344.","journal-title":"Neuropharmacology"},{"key":"1133_CR57","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1124\/mol.106.027318","volume":"70","author":"Y Xiao","year":"2006","unstructured":"Xiao Y, Fan H, Musachio JL, Wei ZL, Chellappan SK, Kozikowski AP, Kellar KJ. Sazetidine-A, a novel ligand that desensitizes alpha4beta2 nicotinic acetylcholine receptors without activating them. Mol Pharmacol. 2006;70:1454\u201360.","journal-title":"Mol Pharmacol"},{"key":"1133_CR58","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1124\/jpet.109.162073","volume":"332","author":"ED Levin","year":"2010","unstructured":"Levin ED, Rezvani AH, Xiao Y, Slade S, Cauley M, Wells C, Hampton D, Petro A, Rose JE, Brown ML, et al. Sazetidine-A, a selective alpha4beta2 nicotinic receptor desensitizing agent and partial agonist, reduces nicotine self-administration in rats. J Pharmacol Exp Ther. 2010;332:933\u20139.","journal-title":"J Pharmacol Exp Ther"},{"key":"1133_CR59","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1124\/jpet.112.194506","volume":"342","author":"SD AlSharari","year":"2012","unstructured":"AlSharari SD, Carroll FI, McIntosh JM, Damaj MI. The antinociceptive effects of nicotinic partial agonists varenicline and sazetidine-A in murine acute and tonic pain models. J Pharmacol Exp Ther. 2012;342:742\u20139.","journal-title":"J Pharmacol Exp Ther"},{"key":"1133_CR60","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.it.2016.10.001","volume":"38","author":"FA Pinho-Ribeiro","year":"2017","unstructured":"Pinho-Ribeiro FA, Verri WA Jr, Chiu IM. Nociceptor sensory neuron-immune interactions in pain and inflammation. Trends Immunol. 2017;38:5\u201319.","journal-title":"Trends Immunol"},{"key":"1133_CR61","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1016\/j.cell.2010.02.016","volume":"140","author":"CK Glass","year":"2010","unstructured":"Glass CK, Saijo K, Winner B, Marchetto MC, Gage FH. Mechanisms underlying inflammation in neurodegeneration. Cell. 2010;140:918\u201334.","journal-title":"Cell"},{"key":"1133_CR62","doi-asserted-by":"publisher","first-page":"3771","DOI":"10.1038\/ncomms4771","volume":"5","author":"T Masuda","year":"2014","unstructured":"Masuda T, Iwamoto S, Yoshinaga R, Tozaki-Saitoh H, Nishiyama A, Mak TW, Tamura T, Tsuda M, Inoue K. Transcription factor IRF5 drives P2X4R+reactive microglia gating neuropathic pain. Nat Commun. 2014;5:3771.","journal-title":"Nat Commun"},{"key":"1133_CR63","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1002\/glia.22770","volume":"63","author":"T Tanaka","year":"2015","unstructured":"Tanaka T, Murakami K, Bando Y, Yoshida S. Interferon regulatory factor 7 participates in the M1-like microglial polarization switch. Glia. 2015;63:595\u2013610.","journal-title":"Glia"},{"key":"1133_CR64","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1073\/pnas.1513853113","volume":"113","author":"IE Papageorgiou","year":"2016","unstructured":"Papageorgiou IE, Lewen A, Galow LV, Cesetti T, Scheffel J, Regen T, Hanisch UK, Kann O. TLR4-activated microglia require IFN-gamma to induce severe neuronal dysfunction and death in situ. Proc Natl Acad Sci U S A. 2016;113:212\u20137.","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Journal of Neuroinflammation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-018-1133-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12974-018-1133-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-018-1133-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T03:00:54Z","timestamp":1589511654000},"score":1,"resource":{"primary":{"URL":"https:\/\/jneuroinflammation.biomedcentral.com\/articles\/10.1186\/s12974-018-1133-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,27]]},"references-count":64,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1133"],"URL":"https:\/\/doi.org\/10.1186\/s12974-018-1133-5","relation":{},"ISSN":["1742-2094"],"issn-type":[{"value":"1742-2094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,27]]},"assertion":[{"value":"28 December 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All experimental procedures were approved by the Animal Research Committees of Wakayama Medical University and were carried out in accordance with the in-house guidelines for the care and use of laboratory animals of Wakayama Medical University and the ethical guidelines of the International Association for the Study of Pain.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"96"}}